Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
31.17
-1.43 (-4.39%)
Oct 1, 2026, 2:20 PM EDT - Market open
Viking Therapeutics Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Viking Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $94.82. The average 1-year stock price forecast is 204.20% higher than the current stock price, while the lowest is $38 (+21.91%) and the highest is $125 (+301.03%).
Price Target: $94.82 (+204.20%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Viking Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 13 | 13 | 13 | 13 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Reiterates $85 | Buy | Reiterates | $85 | +172.70% | Sep 25, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $70 | Buy | Reiterates | $70 | +124.57% | Sep 23, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $118 | Buy | Reiterates | $118 | +278.57% | Sep 23, 2026 |
| Jefferies | Jefferies | Buy Maintains $101 | Buy | Maintains | $101 | +224.03% | Sep 23, 2026 |
| Lake Street | Lake Street | Buy Reiterates $89 | Buy | Reiterates | $89 | +185.53% | Sep 23, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.61
from -3.19
EPS Next Year
-4.40
from -4.61
EPS and Forward PE are based on non-GAAP adjusted numbers.